Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibudilast for Oxycodone Self-administration in Opioid Abusers
NCT01740414Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Nov 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibudilast in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Nov 2012; status: completed.
02
Drugs
ibudilast
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01740414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740414.